Experts are eagerly anticipating pozelimab, a investigational treatment showing encouraging results in preliminary clinical studies . This therapeutic targets tau tangles – a significant hallmark of https://socialrus.com/story25381112/pozelimab-a-new-breakthrough-for-the-disease